Focal therapy for prostate cancer: Evidence-based or oversold?
Medscape: Daniel Spratt, professor of radiation oncology, and Jonathan Shoag, associate professor of urology at the School of Medicine, weighed in on the high cost of focal therapy and lack of data surrounding the practice.
